Sorafenib as treatment for relapsed or refractory pediatric acute myelogenous leukemia

Tanya C. Watt, Todd Cooper

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'Sorafenib as treatment for relapsed or refractory pediatric acute myelogenous leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences